Clinical Trials in Cleveland

Showing 8661-8680 of 15,050 trials

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

NCT00768079

The study will evaluate the effect of two intravenous dose regimens of benralizumab (MEDI-563) on the proportion of adult subjects with asthma exacerbations who required an urgent healthcare visit for treatment of an acute asthma exacerbation.

Asthma

MedImmune LLC110 participantsStarted Feb 2009

Tampa, Florida, United States • Springfield, Massachusetts, United States • Detroit, Michigan, United States +8 more locations

COMPLETEDPhase 3< 1 mile

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT00471497

In this study, the efficacy and safety of two nilotinib doses, 300 mg twice daily and 400 mg twice daily, were compared with imatinib 400 mg once daily in newly diagnosed patients with Philadelphia chromosome-positive (Ph+) Chronic Myelogenous Leukemia in the chronic phase (CML-CP). An extension protocol was included in this study design to allow patients who did not show sufficient response to their assigned treatments the opportunity to receive imatinib 400 mg BID (option available until protocol amendment 7) or nilotinib 400 mg BID, using an abbreviated safety and efficacy assessment schedule.

Myelogenous Leukemia, Chronic

Novartis Pharmaceuticals846 participantsStarted Jul 2007

Los Angeles, California, United States • San Diego, California, United States • Vallejo, California, United States +210 more locations

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Find Trials by Condition in Cleveland

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Bone Mineral Density in Women With Uterine Fibroids or Endometriosis

TRANSFIX Zenith® Transection Clinical Study

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Quality of Life in Patients With Congenital Afibrinogenemia

Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye

Exploring the Optimal Duration of a Group-based Online Behavioral Weight Loss Program